Procedure-related pain during CT-guided percutaneous transthoracic needle biopsies of lung lesions: a prospective study
Open Access
- 12 June 2023
- journal article
- research article
- Published by Springer Nature in Cancer Imaging
- Vol. 23 (1) , 1-7
Abstract
Background: The existing data on the degree of pain in patients during CT-guided percutaneous transthoracic needle biopsy (PTNB) of lung lesions are limited and the factors related to pain are unclear. In this study, we aimed to evaluate the prevalence and severity of pain reported during PTNB and to identify factors associated with increased reported pain. Methods: Patients who underwent PTNB from April 2022 to November 2022 were prospectively evaluated using the numeric rating scale, which assesses subjective pain based on a 0–10 scoring system (0 = no pain; 10 = the worst pain imaginable). The scale divides the scores into three categories: mild pain (1–3 points), moderate pain (4–6 points), and severe pain (7–10 points). Pain scores from 4 to 10 were considered significant pain. Demographic data of patients, lesion characteristics, biopsy variables, complications, the patient’s subjective feelings, and pathological result data were analyzed by multivariable logistic regression analysis to identify variables associated with significant pain. Results: We enrolled 215 participants who underwent 215 biopsy procedures (mean age: 64.5 ± 9.3 years, 123 were men). The mean procedure-related pain score was 2 ± 2. Overall, 20% (43/215) of participants reported no pain (score of 0), 67.9% (146/215) reported pain scores of 1–3, 11.2% (24/215) reported scores of 4–6, and 0.9% (2/215) reported scores of 7 or higher. Furthermore, non-significant pain (scores of 0–3) was reported during 87.9% (189/215) of the procedures. In the adjusted model, significant pain was positively associated with lesions ≥ 34 mm (p = 0.001, odds ratio [OR] = 6.90; 95% confidence interval [CI]: 2.18, 21.85), a needle-pleural angle ≥ 77° (p = 0.047, OR = 2.44; 95% CI: 1.01, 5.89), and a procedure time ≥ 26.5 min (p = 0.031, OR = 3.11; 95% CI: 1.11, 8.73). Conclusions: Most participants reported no pain or mild pain from CT-guided percutaneous transthoracic needle biopsies of lung lesions. However, those with a larger lesion, a greater needle-pleural angle, and a longer procedure time reported greater pain.Keywords
Funding Information
- Beijing Hospitals Authority’ Ascent Plan (DFL20191103)
- Innovation Cultivation Program project of Peking University Cancer Hospital (KC202212)
- Science and Innovation Cultivation Program project of Peking University Cancer Hospital (KC2312)
This publication has 27 references indexed in Scilit:
- C-Arm Cone-Beam CT–Guided Percutaneous Transthoracic Needle Biopsy of Small (≤ 20 mm) Lung Nodules: Diagnostic Accuracy and Complications in 161 PatientsAmerican Journal of Roentgenology, 2012
- Incidence of and Risk Factors for Pneumothorax and Chest Tube Placement After CT Fluoroscopy–Guided Percutaneous Lung Biopsy: Retrospective Analysis of the Procedures Conducted Over a 9-Year PeriodAmerican Journal of Roentgenology, 2010
- Respiratory Chest Pain: Diagnosis and TreatmentMedical Clinics of North America, 2010
- The use of sedation in the radiology departmentClinical Radiology, 2009
- Accuracy of CT-guided transthoracic needle biopsy of lung lesions: Factors affecting diagnostic yieldLa radiologia medica, 2007
- Liver biopsy: Is the pain for real or is it only the fear of it?Acute Pain, 2007
- Influence of operator experience on performance of ultrasound-guided percutaneous liver biopsyEuropean Radiology, 2004
- Practices of Liver Biopsy in France: Results of a Prospective Nationwide SurveyHepatology, 2000
- Diagnostic Accuracy of CT-Guided Automated Needle Biopsy of Lung NodulesAmerican Journal of Roentgenology, 2000
- When is cancer pain mild, moderate or severe? Grading pain severity by its interference with functionPain, 1995